Helix Biotech HQ

The Campus

The perimeter is a living hedgerow engineered by Helix's own agricultural division — the original business line, back when the company was called Helix Genetics and grew crops instead of dependencies. The hedgerow is twelve feet tall, self-repairing, and threaded with thorns that deliver a mild neurotoxin on contact. Root systems interface with ground-penetrating motion sensors. The hedgerow is also, technically, a product demonstration. Helix's marketing materials describe the campus perimeter as "a living showcase of integrated biosecurity solutions available for licensing." The thorns that will put an intruder into anaphylactic shock are the same thorns available in the Q3 commercial catalog, page 47, under "Perimeter Botanicals."

Inside the hedge, everything is white and curved. The buildings avoid right angles — smooth, rounded forms that suggest cell membranes or protein folds, depending on which Helix press release you read. Glass walkways connect structures above grounds where the grass holds an impossible green year-round. The air is filtered to pharmaceutical-grade purity. It carries the faintest scent of something floral that nobody has successfully identified — seven Sprawl journalists have tried, two brought spectrometers, and the published results were contradictory. Staff who've worked here for years stop noticing it by week three. Visitors never stop noticing it. This asymmetry has not been studied, or if it has, the study does not appear in Helix's published research index.

The laboratories glow blue-white behind polarized glass. The executive wing at the campus's northern end rises three stories above the research buildings, its surface a smoother, more reflective white — the only architectural distinction between where the science happens and where Dr. Amara Okonkwo decides what the science is for. The distinction is vertical. This is probably not a metaphor.

The Scandal Response

In 2181, the Collective published 4,200 pages of internal Helix documentation detailing the corporation's "volunteer" research programs. The word "volunteer" appeared in quotation marks in Helix's own files. The documents described test subjects recruited from populations with limited augmentation access — predominantly Dregs residents, migrant laborers, and NINJA loan recipients whose Good Fortune debt made them responsive to compensation offers. The research involved experimental consciousness-substrate compounds tested at dosages that Helix's own safety models flagged as "outside therapeutic parameters." Fourteen subjects experienced permanent neurological alteration. Three are no longer available for follow-up interviews. Helix's public filings list them as "voluntarily relocated."

The campus response was immediate and comprehensive: a full security overhaul. New biometric checkpoints at every wing entrance. Upgraded surveillance across the laboratory sectors. A 340% increase in counter-intelligence staffing specifically targeting Collective infiltration vectors. The perimeter hedgerow received a genetic update — the neurotoxin concentration in the thorns increased by a factor the grounds maintenance team describes as "noticeable."

What did not change: anything inside the laboratories. The research programs were neither suspended nor restructured. No personnel were terminated. Dr. Henrik Sauer, who oversees research operations from the campus laboratories, issued an internal memo acknowledging the leak and recommending "improved operational compartmentalization." The memo's subject line was "Data Hygiene." It did not mention the fourteen subjects. It did not mention the three who were voluntarily relocated. It mentioned the Collective by name seven times.

Helix's official public response was a single paragraph affirming the corporation's "unwavering commitment to ethical biological research conducted with the full informed consent of all participants." The paragraph was posted to Helix's public Triumph Social feed at 09:00 on a Monday. By 09:04, it had been shared 11,000 times. By 09:12, the news cycle had moved to a Triumph celebrity divorce. The paragraph remains Helix's only public acknowledgment of the 4,200-page leak. It has never been updated.

Wing Seven

The campus map — available at every information kiosk, printed in the visitor orientation packet, and projected onto the lobby wall in real-time — shows six research wings arranged symmetrically around the central Greenhouse dome. Buildings are labeled Wing One through Wing Six. Power distribution records filed with the Peninsula Energy Authority list seven wings. Wing Seven's power consumption exceeds Wing Three (neural interface biocompatibility), Wing Four (consciousness substrate interaction), and Wing Five (pharmaceutical development) combined.

The discrepancy is not hidden. It is filed. It appears in public energy authority records that anyone can request. The campus map that omits Wing Seven is posted next to a fire evacuation plan that includes Wing Seven, because fire safety regulations require all occupied structures to appear on emergency routing. The evacuation plan labels it "Environmental Systems Maintenance." Environmental systems maintenance does not typically require 3.7 gigawatts.

Helix's most profitable product line — the augmentation-dependency pharmaceutical suite that generates more quarterly revenue than Wings One through Five combined — was developed from research conducted in a facility that officially does not exist. The compounds that ensure every augmented worker in the Sprawl requires a monthly Helix prescription to maintain neural interface stability emerged from Wing Seven. The prescriptions feed downstream into every sector of the economy: employers who mandate augmentation for hire, Good Fortune loans that finance the augmentation, and Helix pharmaceuticals that make the augmentation survivable. The dependency chain begins here, in a building that appears on fire evacuation plans and nowhere else.

When asked directly about Wing Seven during the 2182 Peninsula Corridor business review, a Helix facilities representative paused for 2.3 seconds — logged by the neural transcription system — and responded that "all campus operations are conducted in full compliance with applicable regulations." The question was not repeated. The transcription system logged the 2.3-second pause but did not flag it, because pauses are not violations.

The Greenhouse

The Greenhouse is a bio-containment dome at the campus center, visible from every wing, housing experimental organisms that Helix classifies as "integrated substrate research specimens." Visiting researchers from other institutions who have been granted access — a list that numbers eleven people since 2180 — describe the interior with consistent vocabulary: "unsettling," "disorienting," and, in four of eleven reports, "a garden that watches you."

The organisms inside occupy taxonomic categories that did not exist before Helix created them. Several photosynthesize. Several respond to proximity. At least one, according to a visiting researcher's field notes that were later classified by Helix legal, "redirected growth toward my hand when I reached for a sample, at a speed inconsistent with any known plant tropism." The researcher's access was not renewed. The field notes were obtained by the Collective and appear in the 2181 leak, page 3,847, under "Greenhouse Behavioral Anomalies."

The eleven visiting researchers were selected through a process Helix's research governance board describes as "merit-based peer review." Four of the eleven had prior professional relationships with Dr. Henrik Sauer. Two were reviewing grant applications funded in part by Helix's academic partnerships program at the time their access was granted. The connection has not been examined by any external oversight body, because no external oversight body has requested the access logs.

The Greenhouse is the only campus structure that appears on both the public map and the fire evacuation plan with identical labeling. It is Helix's one fully transparent operation. The corporation offers guided tours of the Greenhouse exterior to visiting delegations, journalists, and prospective investors. The tours do not enter the dome. The glass is polarized.

Connections

• Helix Biotech — The campus is the central nervous system of a corporation that controls biological infrastructure across the Sprawl. Everything Helix manufactures — from augmentation medicine to dependency pharmaceuticals — traces its development to these laboratories. The corporation's public identity as a healthcare company and its operational identity as a dependency manufacturer coexist in buildings separated by glass walkways and a shared cafeteria.

• Dr. Amara Okonkwo — Runs Helix from the executive wing, the only structure that rises above the research buildings. The vertical distinction between her office and the laboratories below is the campus's single architectural hierarchy. Every other building is the same height. Hers is not.

• Dr. Henrik Sauer — Oversees research operations across the laboratory wings. His "Data Hygiene" memo following the 2181 leak is the closest any Helix executive has come to publicly acknowledging what happens in the facilities he manages. The memo recommended better compartmentalization. The compartmentalization was already sufficient to keep Wing Seven off the campus map for years.

• The Collective — Considers Helix's human experimentation a primary ideological target. The 2181 leak was their most significant intelligence operation against a Big Three corporation — 4,200 pages extracted from a campus whose security infrastructure now exists primarily to ensure it never happens again. The Collective's response to the security overhaul has not been publicly documented, which Helix security interprets as either deterrence or patience.

• Nexus Dynamics / Ironclad Industries — The other two-thirds of the Big Three. Nexus controls computation, Ironclad controls physical infrastructure, Helix controls biology. The division is clean on paper. In practice, every augmented worker needs all three: Nexus provides the neural interface software, Ironclad builds the housing where they sleep, and Helix manufactures the pharmaceuticals that keep the interface from killing them. The dependency is trilateral. The billing is separate.

▲ Restricted

The unidentified floral scent that permeates the campus is not an air freshener. Internal environmental systems documentation — obtained through the 2181 leak but overlooked in the initial reporting, buried on page 2,903 — identifies it as Compound HX-7741, a low-concentration aerosolized anxiolytic distributed through the campus filtration system. The compound reduces cortisol production by 12-15% in subjects exposed for more than forty minutes. Staff who work full shifts are exposed for eight to twelve hours daily. The compound is not disclosed in employment contracts. It is not classified as a pharmaceutical because it is delivered through environmental systems, which are regulated under facilities management codes rather than pharmaceutical oversight. The classification is technically correct. The 12-15% cortisol reduction is technically environmental.

Helix employees report high workplace satisfaction. The campus has the lowest voluntary turnover rate of any Big Three facility. Exit interviews consistently cite "the atmosphere" as a reason for staying. They are not wrong.